Cancer-associated fibroblast functions as a road-block in cancer therapy

P De, J Aske, N Dey - Cancers, 2021 - mdpi.com
Simple Summary An overwhelming percentage of deaths in solid tumors are caused by
treatment failure due to the disease's unresponsiveness when tumor cells tolerate treatment …

[HTML][HTML] Single-cell transcriptomics reveals a low CD8+ T cell infiltrating state mediated by fibroblasts in recurrent renal cell carcinoma

YL Peng, LB **ong, ZH Zhou, K Ning, Z Li… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Purpose Recurrent renal cell carcinoma (reRCC) is associated with poor prognosis and the
underlying mechanism is not yet clear. A comprehensive understanding of tumor …

Distinguishing keratoacanthoma from well-differentiated cutaneous squamous cell carcinoma using single-cell spatial pathology

J Veenstra, D Ozog, I Loveless, I Adrianto… - Journal of Investigative …, 2023 - Elsevier
Keratoacanthoma (KA) is a common keratinocyte neoplasm that is regularly classified as a
type of cutaneous squamous cell carcinoma (cSCC) despite demonstrating benign behavior …

Effective dose window for containing tumor burden under tolerable level

MA Masud, JY Kim, E Kim - NPJ Systems Biology and Applications, 2023 - nature.com
A maximum-tolerated dose (MTD) reduces the drug-sensitive cell population, though it may
result in the competitive release of drug resistance. Alternative treatment strategies such as …

Stroma-mediated breast cancer cell proliferation indirectly drives chemoresistance by accelerating tumor recovery between chemotherapy cycles

D Miroshnychenko, T Miti, P Kumar, A Miller, M Laurie… - Cancer research, 2023 - AACR
The ability of tumors to survive therapy reflects both cell-intrinsic and microenvironmental
mechanisms. Across many cancers, including triple-negative breast cancer (TNBC), a high …

Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia–Results from a Multicenter Study

GT Ruan, M Yang, XW Zhang, MM Song… - Journal of …, 2021 - Taylor & Francis
Background Systemic inflammation and cachexia are associated with adverse clinical
outcomes in elderly patients with cancer. The survival outcomes of elderly patients with …

Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model

J Tranel, S Palm, SA Graves, FY Feng, TA Hope - EJNMMI physics, 2022 - Springer
Background The aim of this study is to elucidate the difference in absorbed dose (Dabs)
patterns in radiopharmaceutical therapies between alpha emitters (225Ac) and beta emitters …

Increased spatial coupling of integrin and collagen IV in the immunoresistant clear-cell renal-cell carcinoma tumor microenvironment

AC Soupir, MT Hayes, TC Peak, O Ospina… - Genome biology, 2024 - Springer
Immunotherapy has improved survival for patients with advanced clear cell renal cell
carcinoma (ccRCC), but resistance to therapy develops in most patients. We use cellular …

The impact of the spatial heterogeneity of resistant cells and fibroblasts on treatment response

M MA, JY Kim, CH Pan, E Kim - PLOS Computational Biology, 2022 - journals.plos.org
A long-standing practice in the treatment of cancer is that of hitting hard with the maximum
tolerated dose to eradicate tumors. This continuous therapy, however, selects for resistant …

[HTML][HTML] Assessment of the prognostic value of SPOCK1 in clear cell renal cell carcinoma: a bioinformatics analysis

J Chen, Z Ye, L Liu, B Xuan - Translational Andrology and Urology, 2022 - ncbi.nlm.nih.gov
Background Clear cell renal cell carcinoma (ccRCC) is one of the most common urological
malignancies, and once metastasis occurs, it often has a poor prognosis and lacks effective …